Replimune (REPL) Tax Provisions (2023 - 2025)
Replimune's (REPL) quarterly Tax Provisions came in at -$311000.0 in Q4 2025, down 154.09% year-on-year from $575000.0 in Q4 2024, and down 211.0% quarter-over-quarter from -$100000.0 in Q1 2025.
Replimune (REPL) Tax Provisions (2023 - 2025) Analysis & Trends
Replimune has disclosed Tax Provisions across 3 years of filings, most recently posting -$311000.0 for Q4 2025.
- Tax Provisions for Q4 2025 came in at -$311000.0, down 154.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $164000.0 (down 67.84% YoY), and the FY2025 annual result was $500000.0, up 22.55% from the prior year.
- Tax Provisions came in at -$311000.0 for Q4 2025 at Replimune, down from -$100000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $575000.0 in Q4 2024 to a low of -$311000.0 in Q4 2025.
- The 3-year median for Tax Provisions is $68000.0 (2023), against an average of $107500.0.
- Across the five-year window, Tax Provisions grew 21.56% in 2024 and slumped 154.09% in 2025, its largest moves.
- Replimune's Tax Provisions stood at $473000.0 in 2023, then advanced by 21.56% to $575000.0 in 2024, then plunged by 154.09% to -$311000.0 in 2025.
- The last three Tax Provisions figures came in at -$311000.0 (Q4 2025), -$100000.0 (Q1 2025), and $575000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | -311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -311,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Mar 31, 2024 | -65,000.00 |
| Dec 31, 2023 | 473,000.00 |
| Sep 30, 2023 | -201,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 288,000.00 |